help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 28, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1805
A more recent version of this article appeared on November 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/11/4107    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maki, P. M.
Right arrow Articles by Resnick, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maki, P. M.
Right arrow Articles by Resnick, S. M.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Male Endocrinology

Submitted on August 16, 2006
Accepted on August 16, 2007

Intramuscular Testosterone Treatment in Elderly Men: Evidence of Memory Decline and Altered Brain Function

Pauline M. Maki*, Monique Ernst, Edythe D. London, Kristen L. Mordecai, Pamela Perschler, Samuel C. Durso, Jason Brandt, Adrian Dobs, and Susan M. Resnick

University of Illinois at Chicago, National Institute of Mental Health, UCLA - David Geffen School of Medicine, Rosalind Franklin University of Medicine and Science, Johns Hopkins School of Medicine, and National Institute on Aging

* To whom correspondence should be addressed. E-mail: pmaki{at}psych.uic.edu.

Context. Recent clinical trials of intramuscular testosterone in eugonadal men suggest positive effects on verbal memory, but other studies find no effect.

Objective. To determine whether supraphysiological testosterone influences verbal memory and brain function during a verbal memory task in healthy eugonadal older men.

Design. Randomized, double-blind, placebo-controlled crossover trial involving 9 months of participation per participant.

Setting. Hospital-based research facility.

Patients. Fifteen cognitively normal men, aged 66 to 86 years.

Intervention. Testosterone enanthate (200 mg IM every other week for 90 days) crossed over with placebo (sesame oil vehicle IM) with a 90-day washout between treatments.

Main Outcome Measures. Performance on a standardized verbal memory test and brain activity (relative glucose metabolic rates) in medial temporal and frontal regions measured with positron emission tomography during a verbal memory task.

Results. Treatment increased total testosterone by 241%. Behavioral results showed a significant decrease in short delay verbal memory with treatment (p < .05, effect size = 0.59 standard deviation) and a nonsignificant decrease on a composite verbal memory measure (p = .09, effect size = 0.48 standard deviation). PET scans revealed decreased relative activity in ventromedial temporal cortex, (i.e., right amygdala/entorhinal cortex) and increased relative activity in bilateral prefrontal cortex with treatment.

Conclusions. Decreased verbal memory and altered relative activity in medial temporal and prefrontal regions suggests possible detrimental effects of supraphysiological testosterone supplementation in elderly men. The results do not rule out potential benefits with other regimens, cognitive tests, or populations.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society